Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

Clinical trial NCT05884801 · UNKNOWN

Trial details

NCT number: NCT05884801
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-06-30
Primary completion: 2025-01-30
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.